zoom_in Click to enlarge

Gregg Semenza

▲ ▼

description Gregg Semenza Overview

Gregg Semenza is an American physician-scientist at Johns Hopkins University who shared the 2019 Nobel Prize in Physiology or Medicine. He was awarded the prize for his foundational discoveries of how cells sense and adapt to oxygen availability, specifically through his identification of hypoxia-inducible factor 1 (HIF-1). This protein complex serves as a primary transcriptional regulator of cellular oxygen homeostasis and plays a critical role in physiological responses to low oxygen levels.

help Gregg Semenza FAQ

What did Gregg Semenza discover about low oxygen?

Semenza identified hypoxia-inducible factor 1, commonly called HIF-1, as a key regulator of cellular responses to low oxygen. HIF-1 controls genes involved in processes such as red-blood-cell production, metabolism, and new blood-vessel formation.

Who shared the 2019 Nobel Prize with Gregg Semenza?

Semenza shared the 2019 Nobel Prize in Physiology or Medicine with William G. Kaelin Jr. and Sir Peter J. Ratcliffe. The prize recognized their discoveries of how cells sense and adapt to oxygen availability.

Where did Gregg Semenza conduct his HIF-1 research?

Semenza carried out his landmark work at Johns Hopkins University in Baltimore. His research connected oxygen sensing to the regulation of the erythropoietin gene and then to a much broader cellular pathway.

Why is the HIF pathway important in cancer research?

Solid tumors often contain oxygen-poor regions, and HIF signaling can help cancer cells adapt to that environment. The pathway can promote altered metabolism and blood-vessel growth, making it an important therapeutic target.

swap_horiz

Looking for Gregg Semenza alternatives? Compare top competitors ranked & scored

arrow_forward